Please try another search
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer’s disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.
Name | Age | Since | Title |
---|---|---|---|
Gian Domenico Trombetta | 63 | - | Member of Strategic Advisory Board |
Tucker Andersen | - | - | Member of Strategic Advisory Board |
Leonard A. Osser | 77 | - | Member of Strategic Advisory Board |
Leslie Bernhard | 80 | 2023 | Independent Chairperson of the Board |
Ben V. Hu | 67 | - | Independent Director |
Irene Cergnul | - | - | Member of Medical Advisory Board |
Abraham Scheer | - | - | Member of Medical Advisory Board |
William A. Hudson | - | 2024 | Member of Military & Government Advisory Board |
Alan Kazden | 63 | 2019 | Independent Director |
Nancy White | - | - | Member of Medical Advisory Board |
Mark White | 62 | 2018 | President, CEO, CFO & Director |
David Owens | 63 | 2017 | Chief Medical Officer & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review